Therapeutic archive
ISSN 0040-3660 (Print)
ISSN 2309-5342 (Online)
Menu
Archives
Home
About the Journal
Editorial Team
Editorial Policies
Author Guidelines
About the Journal
Issues
Search
Current
Archives
Contact
Editorial Board
All Journals
User
Username
Password
Remember me
Forgot password?
Register
Search
Search
Search Scope
All
Authors
Title
Abstract
Index terms
Full Text
Browse
By Issue
By Author
By Title
By Sections
Other Journals
×
User
Username
Password
Remember me
Forgot password?
Register
Search
Search
Search Scope
All
Authors
Title
Abstract
Index terms
Full Text
Browse
By Issue
By Author
By Title
By Sections
Other Journals
Home
>
Search
>
Author Details
Author Details
Калюжин, Олег Витальевич
Issue
Section
Title
File
Vol 90, No 3 (2018)
Editorial
Effect of N-acetylcysteine on mucosal immunity of respiratory tract
(Rus)
Vol 90, No 11 (2018)
Editorial
Clinical and interferon-modulating efficacy of a combination of rectal and topical dosage forms of interferon-α2b in acute respiratory infections
(Rus)
Vol 92, No 12 (2020)
Articles
BCG, muramylpeptides, trained immunity (part I): linkages in the light of the COVID-19 pandemic
(Rus)
Vol 93, No 1 (2021)
Reviews
BCG, muramylpeptides, trained immunity (part II): a low molecular weight alternative to multicomponent bacterial immunostimulants for prevention of respiratory infections during a pandemic
(Rus)
Vol 94, No 7 (2022)
Original articles
New opportunities for preventive anti-inflammatory therapy in the management of patients with moderate and severe COVID-19
(Rus)
Vol 95, No 10 (2023)
Original articles
Efficacy and safety of bacterial lysate OM-85 in the treatment of uncomplicated acute respiratory infections: a double-blind, placebo-controlled, multicenter, randomized trial
(Rus)
Vol 96, No 1 (2024)
Consensuns
Efficacy, safety and prospects of using a combination of native type II collagen, methylsulfonylmethane, boswellic acids, vitamin C and vitamin D
3
in knee osteoarthritis: a resolution of the Expert panel
(Rus)
Vol 95, No 12 (2023)
Original articles
Application of HS221GI in treatment of influenza and ARVI in adults: a new approach – managing virus-induced inflammation. Results of a double-blind, randomized, placebo-controlled, multicenter clinical trial
(Rus)
This website uses cookies
You consent to our cookies if you continue to use our website.
About Cookies
TOP